A Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir in Combination With Rifampin in HIV-1-infected Patients With Tuberculosis

Trial Profile

A Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir in Combination With Rifampin in HIV-1-infected Patients With Tuberculosis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2016

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Rifampicin (Primary) ; Ritonavir (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Jun 2016 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
    • 09 Jun 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Dec 2017.
    • 09 Jun 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top